Bloom Burton analyst Prasath Pandurangan maintained a Buy rating on ESSA Pharma (EPIX – Research Report) today and set a price target of $35.00. The company's shares closed last Friday at $4.84, close to its 52-week low of $4.48. According to TipRanks.com, Pandurangan is ranked #7522 out of 7950 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ESSA Pharma with a $20.00 average price target. See the top stocks recommended by analysts >> Based on ESSA Pharma's latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $10.85 million.
https://www.tipranks.com/news/blurbs/bloom-burton-thinks-essa-pharmas-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral